CL2022001806A1 - Method for producing diphenylmethane derivative. - Google Patents

Method for producing diphenylmethane derivative.

Info

Publication number
CL2022001806A1
CL2022001806A1 CL2022001806A CL2022001806A CL2022001806A1 CL 2022001806 A1 CL2022001806 A1 CL 2022001806A1 CL 2022001806 A CL2022001806 A CL 2022001806A CL 2022001806 A CL2022001806 A CL 2022001806A CL 2022001806 A1 CL2022001806 A1 CL 2022001806A1
Authority
CL
Chile
Prior art keywords
diphenylmethane derivative
producing
synthesis route
synthesis
linear
Prior art date
Application number
CL2022001806A
Other languages
Spanish (es)
Inventor
Yoon Hee-Kyoon
Park Se-Hwan
Yoon Ji-Sung
Choi Soongyu
Jeong Seo Hee
Park Eun-Jung
Kong Younggyu
Song Kwang-Seop
Ju Kim Min
Ok Park So
Original Assignee
Daewoong Pharmaceutical Co Ltd
Green Cross Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daewoong Pharmaceutical Co Ltd, Green Cross Corp filed Critical Daewoong Pharmaceutical Co Ltd
Priority to CL2022001806A priority Critical patent/CL2022001806A1/en
Publication of CL2022001806A1 publication Critical patent/CL2022001806A1/en

Links

Landscapes

  • Saccharide Compounds (AREA)
  • Pyrane Compounds (AREA)

Abstract

La presente invención se refiere a un método mejorado para producir un derivado de difenilmetano que es eficaz como inhibidor del cotransportador de glucosa dependiente de sodio (SGLT), el método se lleva a cabo por medio de un método de síntesis convergente en el cual cada grupo principal se sintetiza por separado y luego se acopla. Como tal, en comparación con un método de síntesis lineal descrito en documentos existentes, la ruta de síntesis es compacta y el rendimiento puede aumentarse, y los factores de riesgo inherentes a la ruta de síntesis lineal pueden reducirse. Además, la forma cristalina del compuesto producido de acuerdo con el método tiene excelentes características fisicoquímicas y, por lo tanto, puede utilizarse de manera efectiva en campos como la fabricación farmacéutica.The present invention refers to an improved method for producing a diphenylmethane derivative that is effective as an inhibitor of the sodium-dependent glucose cotransporter (SGLT), the method is carried out by means of a convergent synthesis method in which each group main is synthesized separately and then coupled. As such, compared to a linear synthesis method described in existing papers, the synthesis route is compact and the yield can be increased, and the risk factors inherent in the linear synthesis route can be reduced. Furthermore, the crystalline form of the compound produced according to the method has excellent physicochemical characteristics and therefore can be effectively used in fields such as pharmaceutical manufacturing.

CL2022001806A 2022-07-01 2022-07-01 Method for producing diphenylmethane derivative. CL2022001806A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CL2022001806A CL2022001806A1 (en) 2022-07-01 2022-07-01 Method for producing diphenylmethane derivative.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CL2022001806A CL2022001806A1 (en) 2022-07-01 2022-07-01 Method for producing diphenylmethane derivative.

Publications (1)

Publication Number Publication Date
CL2022001806A1 true CL2022001806A1 (en) 2023-04-14

Family

ID=86337436

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2022001806A CL2022001806A1 (en) 2022-07-01 2022-07-01 Method for producing diphenylmethane derivative.

Country Status (1)

Country Link
CL (1) CL2022001806A1 (en)

Similar Documents

Publication Publication Date Title
CO2018014018A2 (en) Method to produce diphenylmethane derivative
CO6220977A2 (en) TOTAL SYNTHESIS OF SALINOSPORAMIDA A AND ANALOGS OF THE SAME
CO6460770A2 (en) SULFONATED INTERNAL OLEFINE SURFACTANT TO IMPROVE OIL RECOVERY
CO6660478A2 (en) Internal olefin sulfonated surfactant for improved oil recovery
CL2012000581A1 (en) Process for the preparation of 1-chloro-4- (ß-d-glucopyranos-1-yl) -2- [4-tetrahydrofuran-3-yloxy-benzyl] -benzene with phase separation mediated by the addition of acids.
CY1111045T1 (en) METHOD OF PRODUCTION OF A PRODUCER OF FUELZIMIDAZOL
CO6341574A2 (en) COMPOSITIONS OF DL PD-1 ANTAGONISTS AND METHODS OF USE
UY30662A1 (en) DISCONTINUOUS CRYSTALLIZATION METHOD FOR CRYSTALLIZING AN ANTI-HTNFALFA ANTIBODY, ANTIBODY CRYSTALS OBTAINED BY SUCH METHOD, COMPOSITIONS CONTAINING THEM AND APPLICATIONS
AR106987A1 (en) DIAMINE-ARILSULFONAMIDE COMPOUNDS REPLACED WITH HYDROXIALYCHILAMINE AND HYDROXYCYCALYLAMINE WITH SELECTIVE ACTIVITY IN VOLTAGE ACTIVATED SODIUM CHANNELS
MX2012001463A (en) Process for the manufacture of pharmaceutically active compounds.
ECSP109987A (en) METHODS AND USEFUL COMPOUNDS TO PREPARE INHIBITORS OF THE 2-GLUCOSE CO-TRANSPORTER SODIUM
RU2014116637A (en) NON-IONOGENEOUS SURFACE-ACTIVE SUBSTANCES FOR INTENSIFIED PRODUCTION OF RAW OIL
CO6280526A2 (en) HYDROGENATION OF MULTI-BROMATED ALKANS
CL2022001806A1 (en) Method for producing diphenylmethane derivative.
AR110859A2 (en) A PROCESS TO REDUCE OR ELIMINATE INCRUSTATIONS DURING PHOSPHORIC ACID PRODUCTION
EA201300150A1 (en) METHOD OF MANUFACTURING A PRODUCT CONTAINING GALACT-OLIGOSACCHARIDES AND OBTAINED BASED ON A METHOD OF A PRODUCT
GT200200253A (en) HETEROARIL NITRILOS
CO6400148A2 (en) PROCESS FOR THE PRODUCTION OF BIVALIRUDINE
AR057291A1 (en) PROCESS FOR THE PREPARATION OF GEMINAL BISPHOSPHONIC ACIDS AND THE PHARMACEUTICALLY ACCEPTABLE SALES AND / OR HYDRATS OF THE SAME, A PHARMACEUTICAL COMPOSITION THAT CONTAINS AND THE USE OF THIS IN THE TREATMENT OF OSTEOPOROSIS
GT200600072A (en) PHARMACEUTICAL COMPOSITIONS
BR112023020658A2 (en) SYNTHESIS OF COMPOUNDS ANALOGUE TO RAPAMYCIN
CO6511258A2 (en) PHOTOCHEMICAL PROCESS TO PREPARE ARTEMISININE
GT200300083A (en) SELECTIVE INHIBITORS OF CICLOOXIGENASA-2
BR112023000227A2 (en) PROCESS FOR PREPARING DYSMIN
UY30974A1 (en) METHOD FOR TREATING PAIN MEDIATED BY CB2 RECEIVERS (II)